- Reaffirms FY08 EPS guidance
(Note on 7/02) Guides FY08 $2.95-3.05 v $3.52e, FY08 Rev "in the $81B range" v $80.9Be

- Q2 Medical Care Ratio 83.2% v 83.2% y/y
- Q2 Operating Margin 3.3% v 7.2% y/y

Other headlines for [UNH]

• UNH Today 07:40am
  UnitedHealth Group Inc Guides 2009 Commercial Enrollment down 1-1.5M y/y; Full year decline of 450-800K commercial risk based members- Sees 2009 Medicare advantage enrollemnt up 10-135K y/y - Sees 2009 Medicade more...
  
• UNH Today 00:21am
  UnitedHealth Group Inc Merrill Lynch Raised UNH to Neutral from Sell
  
• Yesterday 08:15am
  Merrill cutting price targets in numerous managed care names- HUM price target cut to $40 from $48 - MGLN price target cut to $44 from $47 - WLP price target remains $48 - CI price target remains more...
  
• UNH Yesterday 07:36am
  UnitedHealth Group Inc Merrill Lynch Raised UNH to Neutral from Sell, price target: $26
  
• UNH Yesterday 07:02am
  UnitedHealth Group Inc Guides FY09 $2.90-3.15 v $2.95 ($2.90-3.19 prior), R $85-86B v $80.8Be ($84-86B prior)- The company provided its FY09 outlook back on 10/16, noting that "There is room for upside in our 2009 earnings more...
  

Healthcare sector headlines

• NCST Today 09:48am
  Nucryst Pharmaceuticals Corp Majority holder calls for special meeting of shareholders to consider a return of capital of $0.80/shr
  
• GNBT Today 09:30am
  Generex Biotechnology Announces Positive Results of Metformin Chewing Gum Trial- Results of this fully compliant ICH-GCP conducted study indicate that the MetControl Metformin chewing gum and traditional Metformin tablets more...
  
• Today 09:30am
  Fed sets overnight reverse repos, accepts $25B
  
• 4568.JP Today 09:28am
  Daiichi Sankyo Co Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology- Results from three studies of its investigational molecule, DU-176b, will more...
  
• GENZ Today 09:22am
  Genzyme Corp European Patent on cross-linked Gel Slurries has been revoked by EPO board of appeal- Announces that the opposition they filed against European Patent EP 0466300 B1 to Genzyme Corporation has been more...